Not all pressure injury prevention technologies are equal — and the marketing claims make it hard to tell the difference.
From SEM measurement to thermography to near-infrared spectroscopy to motion sensors, the landscape is crowded, the regulatory nuances matter, and the clinical evidence varies widely. Making the wrong call has real consequences for patients and for your facility.
In this session, Dr. Rhonda Sullivan breaks down the current pressure injury prevention technology landscape — by mechanism, FDA clearance status, and clinical evidence — so you can ask better questions, evaluate vendor claims with confidence, and make decisions grounded in science.
What You’ll Learn
- How each technology category works — and what it is (and isn’t) designed to detect
- FDA clearance status, device classification, and indications for use across the major technology types
- Strength of clinical evidence for each category, and red flags to watch for in vendor-supplied data
- The right questions to ask before adding any technology to your PI prevention program
Why It Matters
Hospital-acquired pressure injuries affect an estimated 2.5 million patients annually in the U.S. and carry significant clinical, financial, and regulatory consequences. As technology adoption accelerates, clinical leaders need a framework for evaluation — not just vendor demonstrations. This session gives you that framework.